Letrozole 2.5 mg Dosage: A Promising Treatment for Hormone-Receptor Positive Breast Cancer

Letrozol 2.5 mg is a medication that falls under the category of aromatase inhibitors. It is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. The active ingredient in Letrozol is letrozole, which works by reducing the levels of estrogen in the body. Estrogen is a hormone that plays a crucial […]

Letrozole 2.5 mg Dosage: A Promising Treatment for Hormone-Receptor Positive Breast Cancer Read More »